Sign In
Buy BIO
$301.90
-2.46 (-0.81%)
At Close: Jul 20, 2026
The Global Respiratory Syncytial Virus (RSV) Diagnostics Market will grow by $585.17 million during 2020-2024
Bio-Rad (BIO) to Report Q2 Earnings: What's in the Offing?
12:29pm, Monday, 27'th Jul 2020
Strength in product demand related to COVID-19 testing and research is likely to have aided Bio-Rad's (BIO) performance in second-quarter 2020 amid the coronavirus-led economic doldrums.
Global Research Antibodies Market, 2020 - ResearchAndMarkets.com
12:00am, Monday, 27'th Jul 2020
The
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
12:00am, Sunday, 26'th Jul 2020
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured stocks.
Although there were promising updates from...
Earnings Season Watch List: Bio Rad Labs Hits New Highs
11:31pm, Friday, 24'th Jul 2020
To get ready for earnings season, look for stocks in or near a potential buy zone ahead of their next quarterly report. One company that fits that bill is Bio Rad Labs (BIO). It's expected to release
The Daily Biotech Pulse: Mixed Tidings From Novavax, Radius Health Out-licenses Breast Cancer Drug, 3 IPOs
12:00am, Friday, 24'th Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 23)
Abbott Laboratories (NYSE: ABT)
ABIOMED, Inc. (NASDAQ: ABMD)
Acceleron Pharma Inc (NASDAQ: XLRN)
Aerpio...
Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for
04:32pm, Thursday, 23'rd Jul 2020
Bio-Rad (BIO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results
12:00am, Thursday, 23'rd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 22)
ABIOMED, Inc. (NASDAQ: ABMD)
Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO)
Bio-Rad Laboratories,...
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
12:00am, Wednesday, 22'nd Jul 2020
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 21)
ABIOMED, Inc. (NASDAQ: ABMD)
Assembly Biosciences Inc (NASDAQ: ASMB)
Bio-Rad Laboratories, Inc. (NYSE: BIO)...
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Purchased by Parallel Advisors LLC
07:30am, Tuesday, 21'st Jul 2020
Parallel Advisors LLC raised its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) by 22.0% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission
Gateway Investment Advisers LLC Buys New Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)
06:30am, Monday, 20'th Jul 2020
Gateway Investment Advisers LLC bought a new stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Comm
$3.5 Bn Blood Screening Market by Technology, Product, End-user and Region - Forecast to 2025 - ResearchAndMarkets.com
12:00am, Monday, 20'th Jul 2020
The
Bio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by CENTRAL TRUST Co
07:46am, Friday, 17'th Jul 2020
CENTRAL TRUST Co decreased its stake in Bio-Rad Laboratories, Inc. (NYSE:BIO) by 57.4% during the 2nd quarter, HoldingsChannel reports. The firm owned 876 shares of the medical research company’s st
In-Vitro Diagnostics Market: Analysis, Trends and Forecasts to 2028 - ResearchAndMarkets.com
12:00am, Friday, 17'th Jul 2020
The
Bio-Rad to Report Second-Quarter 2020 Financial Results, Thursday, July 30, 2020
12:01am, Thursday, 16'th Jul 2020
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the second quarter 2020 on Thursday, July
